Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Charcot-Marie-Tooth type 4 C misdiagnosed as CIDP: electrodiagnostic pitfalls and genetic confirmation.

Neurogenetics·2026
Same author

Successful Management of Transfusion-Dependent Unstable Hemoglobin Perth with Splenectomy: First Report from Iran and Literature Review.

Hemoglobin·2026
Same author

Expanding the genetic and clinical landscapes of hereditary spastic paraplegia (HSP): a cohort study of 103 families.

Orphanet journal of rare diseases·2026
Same author

Identification of Two Rare Variants in Iranian Families With Familial Sudden Cardiac Death.

International journal of genomics·2026
Same author

Biallelic Variant in NRDC Gene in Two Siblings With Developmental Delay and Seizures.

American journal of medical genetics. Part A·2025
Same author

Combining re-evaluation and new exome sequencing to identify novel genetic variants and candidate genes in Iranian families with non-syndromic hearing loss.

Molecular biology reports·2025
Same journal

Erratum : A Novel Insight into Endothelial and Cardiac Cells Phenotype in Systemic Sclerosis Using Patient-Derived.

Cell journal·2026
Same journal

Conditioned Medium from Muramyl Dipeptide-Primed Mesenchymal Stem Cells Enhances Therapeutic Efficacy in Experimental Rheumatoid Arthritis.

Cell journal·2026
Same journal

Identification and Verification of Key Genes Underlying Methamphetamine Sensitization Using Network-Based Analysis.

Cell journal·2026
Same journal

Regulatory T Lymphocyte-Derived Extracellular Vesicles Play A Role in Chronic Kidney Diseases and Kidney Transplantation: A Review.

Cell journal·2026
Same journal

Comment on: miR-129-5p Modulates Fndc5 Expression in Adipose Tissue of Diabetic Mice.

Cell journal·2026
Same journal

Baicalein Alleviates Brain Tissue Injury in Rats with Posterior Circulation Ischemic Vertigo by Repressing The TLR4/NF-κB Pathway.

Cell journal·2026
See all related articles

Related Experiment Video

Updated: May 4, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

9.3K

Optimizing A Lipocomplex-Based Gene Transfer Method into HeLa Cell Line.

Alimohammad Asgharian1, Mehdi Banan2, Hossein Najmabadi2

  • 11.Department of Cell and Molecular Biology, Islamic Azad University, Tonekabon Branch, Tonekabon, Iran.

Cell Journal
|January 2, 2014
PubMed
Summary
This summary is machine-generated.

FuGENE-HD is an efficient cationic lipid reagent for gene delivery into HeLa cells, showing high transfection efficiency and low toxicity compared to other reagents. This optimization is crucial for successful gene expression studies in mammalian cell lines.

Keywords:
HeLa CellsLipidsTransfection

More Related Videos

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

8.1K
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

17.3K

Related Experiment Videos

Last Updated: May 4, 2026

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA
08:29

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

Published on: February 1, 2019

9.3K
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

8.1K
Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety
14:03

Transduction of Human Cells with Polymer-complexed Ecotropic Lentivirus for Enhanced Biosafety

Published on: July 24, 2011

17.3K

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biotechnology

Background:

  • Gene expression studies rely on efficient gene transfer into cell cultures.
  • Viral and non-viral methods exist, with cationic lipid reagents emerging for mammalian cell transfection.
  • HeLa cells are a widely used model system in biological research.

Purpose of the Study:

  • To optimize lipocomplex-based transient gene transfection procedures in HeLa cells.
  • To evaluate and compare the efficiency and toxicity of different cationic lipid reagents.
  • To determine optimal conditions for high gene delivery rates and minimal cell toxicity.

Main Methods:

  • Experimental optimization of transfection using FuGENE-HD, Lipofectamine™2000, and X-tremeGENE.
  • Testing various volumes of transfection reagents and HeLa cell densities.
  • Assessing transfection efficiency via beta-galactosidase staining and cell toxicity using the trypan blue method.

Main Results:

  • FuGENE-HD at 4µl with 10^5 HeLa cells achieved the highest transfection efficiency (43.66 ± 1.52%).
  • FuGENE-HD demonstrated significantly higher efficiency compared to Lipofectamine™2000 and X-tremeGENE.
  • Cell toxicity with FuGENE-HD was below 5%, indicating a favorable safety profile.

Conclusions:

  • FuGENE-HD is a highly efficient and low-toxicity reagent for DNA delivery into HeLa cells.
  • The optimized protocol using FuGENE-HD is suitable for in vitro gene delivery applications.
  • Further research optimizing FuGENE-HD for other cell lines is warranted due to its efficacy.